Lobbying · Company
Eli Lilly
Meetings with ministers
23
In the last 12 months
2
Different ministers
9
Lobbying firms used
1
Meetings with ministers
| Date | Minister | Purpose, as published |
|---|---|---|
| 23 March 2026 | Patrick VallanceDSIT | To discuss UK commercial environment |
| 4 March 2026 | Sir Keir StarmerPrime Minister | Video meeting to discuss UK competitiveness and investment opportunities in the pharmaceutical and life sciences sectors |
| 1 September 2025 | Patrick VallanceDSIT | To discuss the life sciences sector |
| 16 June 2025 | Patrick VallanceDSIT | To include various topics with inward investors including clinical trials, regulatory alignment and scientific collaboration. |
| 2 June 2025 | Patrick VallanceDSIT | To discuss the pharmaceutical landscape in the UK |
| 23 May 2025 | Patrick VallanceDSIT | To discuss the pharmaceutical landscape in the UK |
| 2 April 2025 | Rachel ReevesHMT | Meeting to discuss investment ahead of the Biopharmaceutical CEO Roundtable |
| 2 April 2025 | Sir Keir StarmerPrime Minister | Biopharmaceuticals CEOs Roundtable to discuss global health challenges and life sciences policy |
| 2 April 2025 | Peter KyleDSIT | Roundtable discuss issues facing life sciences in the UK, including VPAG, clincial trials, and health data |
| 2 April 2025 | Jonathan ReynoldsDBT | To discuss the policy environment for the life sciences sector in the UK |
| 2 April 2025 | Poppy GustafssonDBT | To discuss the UK life sciences commerical environment and investment in this sector |
| 2 April 2025 | Wes StreetingDHSC | To discuss life sciences |
| 2 April 2025 | Patrick VallanceDSIT | Biopharmaceutical CEO Roundtable (BCR) Ministerial Policy Roundtable |
| 27 March 2025 | Patrick VallanceDSIT | To discuss company views on the industrial strategy |
| 24 March 2025 | Patrick VallanceDSIT | Attendance at a roundtable alongside key stakeholders, to discuss the UK Government�s ambition for life sciences and priorities and perspectives on dementia research and new treatments. |
| 5 February 2025 | Stephen KinnockDHSC | To discuss dementia |
| 20 November 2024 | Patrick VallanceDSIT | To speak at a life sciences breakfast event with parliamentarians and sector experts |
| 14 October 2024 | Rachel ReevesHMT | Roundtable at the International Investment Summit to discuss the UK's Life Sciences sector. |
| 13 October 2024 | Keir StarmerPrime Minister | Informal engagement at No 10 prior to the International Investment Summit |
| 13 October 2024 | Peter KyleDSIT | To discuss obesity medicine investment in the UK and adoption of innovation in the NHS. |
| 9 October 2024 | Patrick VallanceDSIT | To discuss the UK life sciences sector. |
| 4 October 2024 | Peter KyleDSIT | To discuss the HMG-Lilly Strategic Partnership on obesity medicines. |
| 3 October 2024 | Wes StreetingDHSC | To discuss life sciences and innovation |
Consultant lobbying firms
- IPG DXTRA (UK) LIMITEDApril to June 2026
